Skip to main content
DHX
NYSE Trade & Services

DHI Group Seeks Shareholder Approval for 3.3M New Equity Plan Shares and Announces Auditor Change

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$2.8
Mkt Cap
$135.809M
52W Low
$1.21
52W High
$3.34
52W Position info
131% above low
Off High info
16% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

DHX has more than doubled off its 52-week low of $1.21.

Summary

DHI Group filed its definitive proxy statement, seeking shareholder approval for significant increases in its equity compensation plans (totaling 3.3 million shares) and an Employee Stock Purchase Plan, while also disclosing a change in its independent auditor from Deloitte to RSM US LLP.


Key Events · Corporate Governance and Compliance · DHX

  • Proposed Increase in Equity Award Plan Shares

    DHI Group is seeking shareholder approval to add 2,800,000 shares to its 2022 Omnibus Equity Award Plan. If all authorized shares were issued, dilution would be approximately 6.38% of current outstanding shares.

  • Proposed Increase in Employee Stock Purchase Plan Shares

    The company also proposes to add 500,000 shares to its Employee Stock Purchase Plan. If all authorized shares were issued, dilution would be approximately 1.14% of current outstanding shares.

  • Change in Independent Auditor

    Deloitte & Touche LLP was dismissed, and RSM US LLP was appointed as the independent registered public accounting firm for fiscal year 2026. The company stated there were no disagreements or reportable events with Deloitte.

  • Executive Compensation Details

    The proxy statement provides detailed information on 2025 executive compensation, with annual cash bonuses paid out below target (78.1% to 89.5%) and Performance Stock Units (PSUs) earned at 78.4% of target, reflecting a challenging macroeconomic environment.


Analysis · DHX · Trade & Services

The most significant aspects of this DEF 14A filing are the proposed amendments to the company's equity compensation plans. The request to authorize an additional 2.8 million shares for the 2022 Omnibus Equity Award Plan and 500,000 shares for the Employee Stock Purchase Plan represents a substantial potential dilution of approximately 7.5% of current outstanding shares. While this is a notable increase, the company emphasizes its historical practice of managing dilution through stock repurchases, which have resulted in a net decrease in shares outstanding over the past three years. This suggests a strategic approach to using equity for talent retention while aiming to mitigate its dilutive impact. The change in independent auditors from Deloitte to RSM US LLP is also an important governance update, though the filing explicitly states there were no disagreements or reportable events, which mitigates potential negative sentiment. Investors should monitor the outcome of these proposals and the company's future share issuance and repurchase activities.

At the time of this filing, DHX was trading at $2.80 on NYSE in the Trade & Services sector, with a market capitalization of approximately $135.8M. The 52-week trading range was $1.21 to $3.34. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DHX - Latest Insights

DHX
May 19, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.66
Real-time Price: $3.79 info
Change: +$0.130 (+4%) info
Market Cap: $177.546M info
DHX
May 05, 2026, 4:36 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.83
Real-time Price: $3.79 info
Change: +$0.960 (+34%) info
Market Cap: $177.546M info
DHX
May 05, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.79
Real-time Price: $3.79 info
Change: +$1.00 (+36%) info
Market Cap: $177.546M info
DHX
Apr 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.15
Real-time Price: $3.79 info
Change: +$0.640 (+20%) info
Market Cap: $177.546M info
DHX
Mar 02, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.75
Real-time Price: $3.79 info
Change: +$1.04 (+38%) info
Market Cap: $177.546M info